Co Diagnostics Inc Quick Ratio (CODX) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Co diagnostics Inc   (NASDAQ: CODX)

Co Diagnostics Inc 's Quick Ratio

CODX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Co Diagnostics Inc 's Cash & cash equivalent, this led to improvement in Co Diagnostics Inc 's Quick Ratio to 2.55, Quick Ratio remained below Co diagnostics Inc average.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Quick Ratio than Co Diagnostics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1083 to 1104.

Explain Quick Ratio?
How much Cash & cash equivalents CODX´s has?
What are CODX´s Current Liabilities?




CODX Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -22.84 % -20.31 % -59.05 % -36.31 % -30.05 %
Y / Y Cash & cash equivalent Change -45.38 % -61.68 % -60.05 % -69.61 % -70.23 %
Quick Ratio MRQ 2.55 1.92 3.36 3.1 3.6
CODX's Total Ranking # 1104 # 1083 # 786 # 714 # 610
Seq. Current Liabilities Change -33.17 % 21.05 % -4.15 % -0.5 % -30.97 %
Seq. Cash & cash equivalent Change -11.32 % -30.74 % 3.85 % -14.36 % -37.79 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 70
Healthcare Sector # 439
Overall Market # 1104


Quick Ratio Statistics
High Average Low
29.46 9.74 0.04
(Sep 30 2017)   (Jun 30 2017)




Financial Statements
Co Diagnostics Inc 's Current Liabilities $ 3 Millions Visit CODX's Balance sheet
Co Diagnostics Inc 's Cash & cash equivalent $ 7 Millions Visit CODX's Balance sheet
Source of CODX's Sales Visit CODX's Sales by Geography


Cumulative Co Diagnostics Inc 's Quick Ratio

CODX's Quick Ratio for the trailling 12 Months

CODX Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -38.89 % -39.39 % -34.77 % -7.65 % 4.58 %
Y / Y Cash & cash equivalent TTM Growth -62 % -66.42 % -64.15 % -60.2 % -52.84 %
Quick Ratio TTM 2.7 2.95 3.56 3.55 4.35
Total Ranking TTM # 3830 # 3789 # 2821 # 3044 # 2543
Seq. Current Liabilities TTM Growth -5.57 % -6.69 % -23.83 % -8.95 % -6.35 %
Seq. Cash & cash equivalent TTM Growth -13.5 % -22.77 % -23.49 % -25.64 % -23.56 %


On the trailing twelve months basis In spite of the year on year decrease in CODX's Current Liabilities to $2.86 millions, cumulative Quick Ratio to 2.7 below the CODX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 195 other companies have achieved higher Quick Ratio than Co Diagnostics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3789 to 3830.

Explain Quick Ratio?
How much Cash & cash equivalents CODX´s has?
What are CODX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 196
Healthcare Sector # 879
Within the Market # 3830


trailing twelve months Quick Ratio Statistics
High Average Low
16.77 8.54 1.1
(Mar 31 2023)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions

Date modified: 2026-09-03T11:39:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.